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Skeletal muscle fibre transitions occur in many biological processes, in response to alterations in
neuromuscular activity, in muscular disorders, during age-induced muscle wasting and in myo-
genesis. It was therefore of interest to perform a comprehensive proteomic profiling of muscle
transformation. Chronic low-frequency stimulation of the rabbit tibialis anterior muscle repre-
sents an established model system for studying the response of fast fibres to enhanced neuro-
muscular activity under conditions of maximum activation. We have conducted a DIGE analysis
of unstimulated control specimens versus 14- and 60-day conditioned muscles. A differential
expression pattern was observed for 41 protein species with 29 increased and 12 decreased
muscle proteins. Identified classes of proteins that are changed during the fast-to-slow transition
process belong to the contractile machinery, ion homeostasis, excitation–contraction coupling,
capillarization, metabolism and stress response. Results from immunoblotting agreed with the
conversion of the metabolic, regulatory and contractile molecular apparatus to support muscle
fibres with slower twitch characteristics. Besides confirming established muscle elements as re-
liable transition markers, this proteomics-based study has established the actin-binding protein
cofilin-2 and the endothelial marker transgelin as novel biomarkers for evaluating muscle
transformation.
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1 Introduction
One of the major aims of modern physiology and biochem-
istry is to understand the integrated function of complex
biological systems. The study of skeletal muscle fibers
represents an especially challenging area of biological re-
search due to the enormous cellular plasticity of this type of
tissue [1–4]. Conventional molecular biological and bio-
chemical methods, traditionally used to investigate physio-
logical mechanisms, are often limited to studying only a few
selected genes or proteins. In contrast, the emergence of
high-throughput genomics and proteomics methods has
opened up new possibilities for more comprehensive
approaches of determining biological processes [5, 6]. MS-
based proteomics technologies promise to be extremely use-
ful in the global cataloguing and quantifying of individual
protein species. The proteomics of cardiac muscle is an
excellent example of a new protein biochemical field that has
made enormous progress [7], since detailed heart protein
reference maps are now available [8]. Due to its more het-
erogeneous nature, the proteomic profiling of skeletal mus-
cle fibres is still in its infancy, but has already made sub-
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stantial contributions to our general understanding of basic
and applied myology. Recent studies have successfully cata-
loged the skeletal muscle proteome from various animal
species [9–14], determined global differences in protein
expression between predominantly slow- versus fast-twitch-
ing fibres [15–18], and have identified novel marker proteins
of muscle growth [19], myoblast differentiation [20], neonatal
fibre necrosis [18], hypertrophy [21], muscular dystrophy [22–
26], dysferlinopathy [27], immobilization-induced atrophy
[28, 29] and ageing-induced sarcopenia [30–34]. In analogy,
based on the findings of an initial proteomic analysis of the
fast-to-slow fibre transformation process using a conven-
tional nonfluorescent method [35], this report describes the
detailed DIGE analysis of the differential expression of the
fast skeletal muscle proteome following chronic low-fre-
quency stimulation.
Skeletal muscle plasticity plays a central role in the
adaptive response to changed physiological demands [2].
Predominantly fast-twitching muscle fibers convert to
slower fibers in response to enhanced neuromuscular ac-
tivity [4], whereby muscle conditioning has been instru-
mental for the development of alternative biomedical treat-
ments such as dynamic cardiomyopathy [36], as well as the
enhancement of our biological understanding of tissue
transdifferentiation [37]. Chronic electrostimulation of fast
muscles results in an improved resistance to fatigue, which
is reflected physiologically by an increase in the time-to-
peak twitch tension and half-relaxation time [38]. An eleva-
tion of aerobic-oxidative capacity, decreased fibre calibre and
changes in the density of distinct muscle proteins, switches
in isoform expression patterns and alterations in protein–
protein interactions are established biochemical and cell
biological hallmarks of transformed skeletal muscles. This
includes: (i) metabolic pathways such as the citric acid cycle,
fatty acid oxidation and the respiratory chain which causes a
drastic increase in enzymes of aerobic substrate oxidation
[39, 40], (ii) the contractile apparatus that undergoes a step-
wise replacement of myosin light and heavy chains from
fast isoforms to their slower counterparts [41, 42], (iii) the
ion-regulatory machinery of the excitation–contraction–
relaxation cycle with a shift from fast to slower isoforms
with respect to the SERCA-type Ca21-ATPases, the voltage-
sensing dihydropyridine receptor, the ryanodine receptor
Ca21-release channel and various Ca21-binding proteins [43,
44], (iv) the neuromuscular junction with distinct changes
in the acetylcholinesterase and the nicotinic acetylcholine
receptor [45, 46] and, (v) a decrease in the supramolecular
interaction pattern between Ca21-regulatory proteins of the
sarcoplasmic reticulum [47].
Here, we have investigated the muscle adaptation pro-
cess in response to enhanced neuromuscular activity by MS-
based proteomics, which has resulted in the identification of
a number of new biological markers of the fast-to-slow tran-
sition process, such as cofilin-2 and transgelin. In the long-
term, the detailed cell biological and physiological character-
ization of the role of these muscle proteins in fibre transdif-
ferentiation may improve diagnostic procedures and/or the
design of future strategies to treat muscle pathologies that
involve fibre transformation.
2 Material and methods
2.1 Materials
CyDye DIGE fluor minimal dyes Cy2, Cy3 and Cy5, electro-
phoresis grade chemicals, IPG strips of pH 3–10 and IPG
buffer of pH 3–10 for IEF and ACN were purchased from GE
Healthcare (Little Chalfont, Bucks, UK). For peptide genera-
tion, sequencing grade-modified trypsin was obtained from
Promega (Madison, WI). Ultrapure Protogel acrylamide
stock solutions were from National Diagnostics (Atlanta,
GA). Primary antibodies were from Affinity Bioreagents,
Golden, CO (mAb IIH11 to the fast SERCA1 isoform of the
Ca21-ATPase; mAb IID8 to the slow SERCA 2 isoform of the
Ca21-ATPase), Sigma, Dorset, UK (mAb MY-32 to the fast
MHCf isoforms IIA, IIB, IID of the myosin heavy chain
(MHC); mAb NOQ7.54D to the slow MHCs isoform of the
MHC), Abcam, Cambridge, UK (pAb ab14133 to cofilin-2;
pAb ab11061 to aB-crystallin; mAb ab21128-9F3 to cardiac
fatty acid binding protein FABP-3) and Everest Biotech,
Upper Heyford, Oxfordshire, UK (pAb EB06281 to transge-
lin/SM22-alpha). Peroxidase-conjugated secondary anti-
bodies were purchased from Chemicon International
(Temecula, CA, USA). Protease inhibitors, Immobilon NC
membranes and chemiluminescence substrates were pur-
chased from Roche Diagnostics (Mannheim, Germany) and
Pierce and Warriner (Chester, UK), Millipore (Bedford, MA),
respectively. All other chemicals used were of analytical
grade and obtained from Sigma Chemical Company, Dorset,
UK.
2.2 Animal model
The rabbit tibialis anterior muscle represents a predomi-
nantly fast-twitching muscle that is composed of four
defined fibre types (I, IIC, IIA and IIB) [48]. Conditioning
of the left hind limb of adult male New Zealand white
rabbits was achieved through chronic tele-stimulation of
the peroneal nerve [38]. Low frequency stimulation was
performed at 10 Hz for 14 or 60 days (n = 3) in the Animal
Facility of the University of Konstanz (Germany) under the
direction of Dr. Dirk Pette (Professor Emeritus of Biology).
The Irish Higher Education Authority and the Deutscher
Akademischer Austauschdienst generously supported labo-
ratory visits to Germany by the Maynooth team. Whole
muscle specimens were dissected from the stimulated left
hind limb and the unstimulated right hind limb and then
quick-frozen in liquid nitrogen. Muscle samples were
stored at 2807C and shipped on dry ice prior to proteomics
analysis.
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2.3 Sample preparation
Skeletal muscle tissue (,250 mg) was ground into a fine
powder using liquid nitrogen and immediately added to
1 mL of DIGE-compatible lysis buffer (9.5 M Urea, 2% w/v
CHAPS, 20 mM Tris, pH 8.0–8.5) and incubated at room
temperature for 1 h. In order to maximize protein yields,
protein samples were sonicated on ice for 3610 s bursts
[26]. Following centrifugation at 14 0006gav for 30 min,
protein fractions were collected, aliquoted and stored at
2807C until further use. All preparative steps were per-
formed at 0–47C in the presence of a protease inhibitor
cocktail [26, 35] to prevent excess proteolytic degradation.
Protein concentration was determined using the Bradford
dye binding assay [49].
2.4 DIGE labelling
Minimal CyDye labelling (GE Healthcare) was performed at
a ratio of 25 mg of protein/200 rmol of CyDye for 2-DE.
Labelled samples were incubated on ice for 30 min in the
dark. The labelling reaction was terminated by the addition
of 10 mM lysine. After a brief centrifugal spin, samples
were incubated on ice in the dark for 10 min [26]. Labelled
protein fractions were utilized immediately for further
analysis or otherwise stored at 2207C. Protein samples were
combined with an equal volume of 26lysis buffer (9.5 M
urea, 2% w/v CHAPS, 2% w/v DTT and 1.6% w/v Pharma-
lyte pH 3–10) followed by in-gel rehydration overnight prior
to IEF [26].
2.5 2-DE
Skeletal muscle extracts were diluted in rehydration solution
(8 M urea, 0.5% w/v CHAPS, 0.2% w/v DTT and 0.2% w/v
Pharmalyte pH 3–10) and applied to 24 cm IPG strips
(pH 3–10, nonlinear (NL), GE Healthcare). Strips were rehy-
drated overnight at room temperature using an in-gel rehy-
dration method [50]. The sample was then subjected to IEFat
0.05 mA/IPG strip for 72 000 Vh at 207C. The strips were
equilibrated in 6 M urea, containing 30% v/v glycerol,
2% w/v SDS, 0.05 M Tris-HCl, pH 8.8 and 0.01% w/v bro-
mophenol blue with the addition of 1% w/v DTT for 15 min.
Subsequently, the strips were equilibrated in the same buffer
without DTT but with the addition of 4.8% w/v iodoaceta-
mide for 15 min [51]. The second dimension was carried out
overnight using a Protean Plus Dodeca Cell system (BioRad
Laboratories, Hemel Hempstead, Herts, UK) at 1 W/gel at
157C and was terminated when the dye front had just
migrated off the lower end of the gels. A total of 12 gels were
analysed with six DIGE gels representing the 0–14d and six
gels the 0–60d changes. Gels were subsequently scanned
using a Typhoon variable mode imager 9400 (GE Health-
care), with a standard pixel volume of 40 000–60 000 for all
scans.
2.6 Expression analysis
Following chronic low-frequency stimulation, expression
changes in muscle proteins were determined by the protein
expression analysis software programme Progenesis (Non-
linear Dynamics, Newcastle upon Tyne, UK). Prior to analy-
sis, individual gels were warped to a single master gel. Since
warping aligns protein spots on all analysed gels, this proce-
dure facilitated spot-matching in downstream analysis. Gels
imported into Progenesis were matched and normalized with
nonspots filtered out on the basis of normalized spot volume.
Prior to ANOVA testing (p,0.01), same spot analysis (SSA)
was used across all gels. SSA confers the same spot outline to
corresponding spots in all gels in the series, eliminating
experimental variation between spots. Proteins found to be
significant were picked for tryptic digestion from Plus-One
silver-stained micropreparative gels.
2.7 MS analysis
Tryptic digests were separated and analysed using a C-18 RP-
column (Unitech, Dublin, Ireland) nano-LC system from
Proxeon Biosystems (Odense, Denmark) connected directly
to an LTQ Linear IT Mass spectrometer (Thermo Finnegan,
Hemel Hempstead, Herts, UK). The samples were eluted
from the C18 precolumn (Proxeon) by an increasing MeCN
gradient (0–90%). Generated mass spectra were searched
against the UNIPROT database (release 7.6) and data col-
lected by the Proline Proteomics Pipeline (Gerard Cagney
Laboratory, UCD Conway Institute) utilizing the X! Tandem
2005.02.01 protein search engine. Parent mass error was
20.5 to 4.0 m/z with fragment error of 0.4 Da. One missed
tryptic cleavage site was accepted per peptide.
2.8 Validation
Validation of selected proteins identified by MS/MS analysis
was carried out by 1-D immunoblot analysis, as previously
described in detail [52]. The electrophoretic transfer of pro-
teins to NC membranes was performed by the method of
Towbin et al. [53]. Primary antibodies to the fast and slow
MHC, the fast and slow sarcoplasmic reticulum Ca21-
ATPase, cofilin-2, aB-crystallin, the cardiac fatty acid bind-
ing-protein FABP-3 and transgelin were used to determine
stimulation-induced changes in the abundance and/or iso-
form expression patterns of key muscle proteins.
3 Results
3.1 Severely altered protein expression pattern in
chronic low-frequency stimulated tibialis anterior
muscle
The comparative gel electrophoretic analysis of unstimulated
versus 14- and 60-day electrostimulated fast muscles revealed
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a drastic change in the 2-D protein separation pattern of
crude tissue extracts following fibre conditioning. The 2-D
spot pattern of silver-stained gels was shown to be very com-
parable to published studies on the position of 2-D landmark
species, such as contractile proteins [9–18], but the stimu-
lated specimens differed considerably to the untreated con-
trol (Figs. 1A, C and E). Building on the recent successful
identification of novel biomarkers for X-linked muscular
dystrophy by DIGE analysis [26], we have here applied the
same fluorescent technology to the comprehensive screen-
Figure 1. 2-D gel electrophoretic analysis of chronic low-fre-
quency stimulated fast muscle. Shown are silver-stained 2-D gels
of unstimulated (A; 0d), 14-day chronic low-frequency stimulated
(C; 14d CLFS) and 60-day stimulated (E; 60d CLFS) fast muscles.
The results of the SSA approach used in the Progenesis 2-D soft-
ware analysis programme is shown in panel B. The image is the
overlay of DIGE-labelled muscle extracts following 0, 14 and
60 day stimulation. Panels D and F illustrate the overlay image of
the CyDye fluors Cy2, Cy3 and Cy5, whereby in both sets Cy2
represents the pooled standard, Cy3 the unstimulated control
sample and Cy5 the 14- or 60-day electrostimulated specimens,
respectively. Shown are DIGE-labelled 2-D gels of unstimulated
versus 14-day chronic low-frequency stimulated muscle (D; 14d-
CLFS), and unstimulated versus 60-day conditioned fast muscle
(F; 60d-CLFS). IEF has been carried out on 24 cm pH 3–10 IPG
strips in the first dimension and standard 12% polyarcylamide
slab gels in the second dimension. The pH-values of the first di-
mension gel system and molecular mass standards (in kDa) of
the second dimension are indicated on the top and on the left of
the panels, respectively. See Figs. 2 and 4 for enlarged images of
individual marker proteins with a changed abundance following
chronic low-frequency stimulation, and Table 1 for a detailed
listing of skeletal muscle proteins with a stimulation-induced
change in their abundance as judged by DIGE analysis.
ing of chronic low-frequency stimulated fast muscle. Al-
though 2-D gels do not represent the entire muscle protein
complement, gel electrophoretic techniques are indis-
pensable tools for the biochemical profiling of complex
proteomes [54], especially in conjunction with modern MS
methods [55]. The differential fluorescent tagging of indi-
vidual sets of proteins and separation within the same gel
electrophoretic system [56–58] has greatly reduced gel-to-gel
variation, and this advantage over other comparative prote-
omic approaches was exploited in this investigation of the
muscle transformation process. As illustrated in Figs. 1D
and F, the overlay images of the CyDye fluors Cy2, Cy3 and
Cy5, representing the pooled standard, the unstimulated
control sample and the 14- or 60-day electrostimulated spe-
cimens, respectively, clearly demonstrated large changes in
the expression pattern of the conditioned fast skeletal mus-
cle proteome. Since the SSA approach used in the Progenesis
2-D software analysis package imparts the same spot outline
between corresponding spots in all investigated gels, the
SSA system was employed. Figure 1B shows the image of
the overlay of DIGE-labelled muscle extracts following 0, 14
and 60 day stimulation, including the pattern of marked
protein spots. Out of an original population of over 2700
2-D spots, 985 protein spots were chosen for SSA handling
after filtering and spot editing. Proteins of interest, which
had been highlighted by expression analysis, were picked
from preparative gels for downstream analysis by ESI-MS/
MS.
3.2 Confirmation of fast-to-slow muscle transition by
contractile marker analysis
In parallel to the in-depth analysis of the differential protein
expression profile of stimulated fast muscles using the
DIGE technique, a successful skeletal muscle transforma-
tion was confirmed by the evaluation of key contractile pro-
tein isoforms. It is well established that the various light
and heavy chains of myosin undergo a stepwise replace-
ment from fast to slow isoforms during fibre type shifting
[41, 42], which has also been shown to occur in the case of
regulatory elements of the contractile apparatus, such as the
individual subunits of troponin [4]. The expanded views of
2-D landmark spots shown in Fig. 2 clearly demonstrated
that the continuous telestimulation of the peroneal nerve at
a frequency of 10 Hz has induced a fast-to-slow transition
process. While a fast-twitch marker protein, such as the fast
isoform of Troponin-I, exhibited a drastic reduction follow-
ing electrostimulation (Fig. 2A), the expression of the slow
isoform of Troponin-T was dramatically increased (Fig. 2B).
The gradual replacement of fast with slow isoforms was also
clearly documented by distinct alterations in the 2-D spot
cluster that represents myosin light chains. The four iso-
forms of interest are individually labelled in Fig. 2C and
clearly illustrated the gradual fast-to-slow transition process
on the molecular level.
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Table 1. List of protein species with a changed expression level following chronic low-frequency stimulation of the rabbit tibialis anterior
muscle
Spot
no.
Accession
no.
Protein Peptides
matched
Peptide sequence Charge Score 0–14d
CLFS
0–60d
CLFS
14d-60d
CLFS
1 P01948 Hemoglobin 11 VNVEEVGGEALGR 2 2100.3 5.197 9.138 1.758
VVAGVANALAHK 2
VNVEEVGGEAL 2
VVAGVANALAH 2
LLVVYPWTQR 2
SAVTALWGK 2
LSELHCDK 2
EFTPQVQAAYQK 2
LHVDPENFR 2
VHLSSEEK 2
VVAGVANAL 1
2 P05413 Cardiac fatty acid
binding protein FABP-3
9 WDGQETTLVR 2 265.1 6.220 8.779 1.411
SLGVGFATR 2
SLGVGFA 1
GQETTLVR 2
SIVTLDGGK 1
NGDILTLK 1
SLGVGF 1
NFDDYMK 1
NTEISFK 1
3 P04792 HSP-27 4 QLSSGVSEIR 2 223.9 2.499 8.322 3.330
QDEHGYISR 2
DGVVEITGK 1
TKDGVVEITGK 2
4 Q9Y281 Cofilin-2 5 YALYDATYETK 2 239.4 2.455 7.594 3.094
ASGVTVNDEVIK 2
MIYASSK 1
WAPESAPLK 2
LLPLNDCR 2
5 P08590 Myosin light chain
MLC1 slow
9 ALGQNPTQAEVLR 2 272.2 1.748 6.626 3.790
ITYGQCGDVLR 2
GQNPTQAEVLR 2
HVLATLGER 2
PTQAEVLR 2
EAFMLFDR 2
LMAGQEDSNG 2
APAPP 1
EGNGTVMGAELR 2
6 P12075 Cytochrome-c oxidase 2 SGGGVPTDEEQATGLER 2 214 3.269 6.302 1.928
CPNCGTHYK 2
7 P41982 Superoxide dismutase 4 EQGHLQIAAC 2 223.7 2.300 5.823 2.532
GELLEAIKR 2
HHAAYVNNLNATEEK 2
NVRPDYLK 2
8 P68136 a-Actin 3 DSYVGDEAQSK 2 223.5 3.041 5.574 1.824
QEYDEAGPSIVHR 2
AGFAGDDAPR 2
9 P13805 Troponin T slow 3 VDFDDIHR 1 216.3 1.899 5.534 2.914
DFDDIHR 1
PVVPP 1
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Table 1. Continued
Spot
no.
Accession
no.
Protein Peptides
matched
Peptide sequence Charge Score 0–14d
CLFS
0–60d
CLFS
14d-60d
CLFS
10 P02563 MHC slow/cardiac 6 QAEEAEEQANTNLSK 1 266.5 2.583 3.905 1.512
VQLLHSQNTSLINQK 1
VQHELDEAEER 2
KVQHELDEAEER 1
AVVEQTER 1
VRELENELEAEQK 1
11 O14558 a Crystallin-related HSP-B6 2 HFSPEEIAVK 2 210 1.858 3.541 1.906
MEIPVPVQPS 1
12 P02645 Troponin I slow 1 GLSLSALQDLCR 2 25.6 1.468 3.262 2.222
13 P41316 aB-crystallin 3 EEKPAVTAAPK 2 218.1 2.291 3.200 1.396
VLGDVIEVHGK 2
HFSPEELK 2
14 P19234 NADH-ubiquinone oxidore-
ductase
3 AAAVLPVLDLAQR 2 222.2 2.410 3.117 1.294
VAEVLQVPPMR 2
GPGFGVQAGL 1
15 P04792 HSP-27 4 TKDGVVEITGK 2 236.5 1.799 3.062 1.702
QLSSGVSEIR 1
QDEHGYISR 2
DGVVEITGK 1
16 P30042 ES1 Protein homologue 3 GVEVTVGHEQEEGGK 2 218.4 2.082 2.943 1.413
NLSTFAVDGK 1
STFAVDGK 1
17 P21796 Voltage-dependent anion
channel 1
3 LTFDSSFSPNTGK 2 227.1 1.634 2.650 1.622
YQIDPDACFSAK 2
VTQSNFAVGYK 2
18 P02170 Myoglobin 12 VEADLAGHGQEVLIR 2 2117.5 1.673 2.518 1.505
HPGDFGADAQ 2
VEADLAGHGQ 2
HPGDFGADAQAAMSK 2
LAGHGQEVLIR 2
VEADLAGHGQEV 2
LFHTHPETLEK 2
LFHTHPETL 2
GHHEAEIKPL 2
HPGDFGADAQA 2
NDIAAQYK 1
GHHEAEIKPLAQ 2
19 P11177 Pyruvate dehydrogenase 4 GPNGASAGVAAQHSQ 2 227.4 3.685 2.511 1.083
VTGADVPMPY 1
DFLIPIGK 1
VTGADVPMPYAK 2
20 Q99LC5 Electron-transferring
flavoprotein
2 TIYAGNALCTVK 2 213.1 2.319 2.511 1.083
QSTLVIAEH 1
21 P49065 Serum albumin 3 ACVADESAANCDK 2 228.3 1.820 2.242 1.232
AILTECCEAADK 2
PEADVLCK 2
22 Q9CZ13 Ubiquinol-Cytochrome-c
reductase
10 MVLAAAGGVEHQ 2 2104.5 1.234 2.025 1.641
QGTPLAQAVEGPSENVR 2
AQAVEGPSENVR 2
LCTSATESEVTR 2
CTSATESEVTR 2
LDGTTPVCEDIGR 2
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Table 1. Continued
Spot
no.
Accession
no.
Protein Peptides
matched
Peptide sequence Charge Score 0–14d
CLFS
0–60d
CLFS
14d-60d
CLFS
TSATESEVTR 2
IPLAEWESR 2
AQAVEGPSEN 2
RIPLAEWESR 2
23 P11974 Pyruvate kinase, muscle
isoform
4 LDIDSAPITAR 2 224.9 1.975 2.005 1.105
GSGTAEVELKK 2
PVAVALDTK 1
GSGTAEVELK 2
24 P25705 ATP synthase,
mitochondrial F1 complex
2 TIEDLNEAFPETK 2 28.9 1.920 1.682 21.138
AGLVDDFEK 2
25 P81605 Proteolysis-inducing factor 3 ENAGEDPGLAR 2 216.1 2.164 1.672 1.294
QKENAGEDPGLA 2
KENAGEDPGLA 2
26 Q9GZV1 Ankyrin, skeletal muscle
isoform
3 FLADGGSADTCDQFR 2 217.1 1.308 1.670 2.183
MDGTMEDSEAVQR 2
EIIDVGGIQN 1
27 P61604 HSP-10 (chaperonin 10) 1 VLLPEYGGTK 1 28.2 2.222 1.627 21.366
28 P04792 HSP-27 4 TKDGVVEITGK 2 226.6 1.129 1.412 1.251
QLSSGVSEIR 1
DEHGYISR 2
QDEHGYISR 2
DGVVEITGKHEER 2
DGVVEITGK 1
SSGVSEIR 1
29 Q01995 Transgelin 2 KYDEELEER 2 210.7 Not
detectable
Not
detectable
Positive
spot at 60dYDEELEER 2
30 P62804 Histone-4 2 ISGLIYEETR 2 212.2 21.266 21.371 21.083
ISGLIYEETR 2
31 P02602 Myosin light chain
MLC 1 fast
7 DQGTYEDFVEGLR 2 249.5 21.078 21.378 21.278
VLGNPSNEEMNAK 2
ALGTNPTNAEVK 2
ALGTNPTNAEVKK 2
ITLSQVGDVLR 2
KVLGNPSNEEMNAK 2
EAFLLYDR 2
HVLATLGEK 2
VLGNPSN 1
ALGTNPTN 1
VFDKEGNGTVMGAELR 2
GTNPTNAEVKK 2
EGNGTVMGAELR 2
32 P30086 Phosphatidylethanolamine
binding protein
3 LYTLVLTDPDAPSR 2 220.8 1.062 22.046 22.173
TLVLTDPDAPSR 2
LYEQLSGK 1
33 P00939 Triosephosphate isomerase 17 HVFGESDELIGQK 2 2183.9 1.076 22.052 22.207
SNVSDAVAQSTR 2
IIYGGSVTGATCK 2
TATPQQAQEVHEK 2
DCGATWVVLGH 2
DCGATWVVLGHSER 2
ELASQPDVDGF 2
TPQQAQEVHEK 2
VAHALSEGLGVIAC 2
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Table 1. Continued
Spot
no.
Accession
no.
Protein Peptides
matched
Peptide sequence Charge Score 0–14d
CLFS
0–60d
CLFS
14d-60d
CLFS
IAVAAQNCYK 2
QAQEVHEK 2
VPADTEVVCAPPTA 2
VTNGAFTGEISPGMIK 2
TGEISPGMIK 2
VVLAY 1
IIYGG 1
YGGSVTGATCK 1
34 P00558 Phosphoglycerate kinase 1 4 FHVEEEGK 2 220.8 21.280 22.718 22.214
DCVGPEVEK 2
ITLPVDFVTADK 2
ALMDEVVK 2
35 P02624 Parvalbumin 9 TLMAAGDKDGDGK 2 274.8 22.184 23.493 21.599
AAAESFDHK 2
MAAGDKDGDGK 2
VFHILDKDK 2
AAGDKDGDGK 2
IGADEFSTLVSES 2
AIGAF 1
TLMAAGDK 1
AGDKDGDGK 1
36 P02643 Troponin I fast 2 SSKELEDMNQK 2 28.3 21.140 24.387 23.848
MSADAMLK 1
37 P14152 Malate dehydrogenase 3 GEFITTVQQR 2 217.2 1.050 24.480 24.705
KLSSAMSAAK 2
LGVTADDVK 1
38 P08507 Glycerol-3-phosphate
dehydrogenase
9 IVGGNAAQLAQFDPR 2 277.9 21.264 24.712 23.727
LPPNVVAVPDVVK 2
ELHSILQHK 2
FCETTIGCK 2
CLQNHPEHM 2
DQAQGQLLK 1
QLMQTPNFR 2
IASEVADEK 2
ANAIGISLIK 2
39 P15122 Aldose reductase 3 REELFIVSK 2 217.7 21.264 24.712 23.727
SPPGQVTEAVK 2
EELFIVSK 1
40 P02608 Myosin light chain MLC 2 8 GADPEDVITGAFK 2 269.9 21.795 25.690 23.170
NICYVITHGDAK 2
PEDVITGAFK 2
EAFTVIDQNR 2
NEELDAMMK 2
ICYVITHGDAK 2
DQTQIQEFK 2
AFPPDVGGNVDYK 2
41 P02603 Myosin light chain
MLC 3 fast
15 DQGTYEDFVEGLR 2 2151.9 23.643 213.208 23.626
VLGNPSNEEMNAK 2
ALGTNPTNAEVK 2
ALGTNPTNAEVKK 2
SFSADQIAEFK 2
ITLSQVGDVLR 2
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Table 1. Continued
Spot
no.
Accession
no.
Protein Peptides
matched
Peptide sequence Charge Score 0–14d
CLFS
0–60d
CLFS
14d-60d
CLFS
KVLGNPSNEEMNAK 2
SADQIAEFK 2
EAFLLYDR 2
HVLATLGEK 2
VLGNPSN 1
ALGTNPTN 1
VFDKEGNGTVMGAELR 2
GTNPTNAEVKK 2
EGNGTVMGAELR 2
Figure 2. 2-D gel electrophoretic analysis of stimulation-induced
changes in key contractile protein isoforms. Shown is an
expanded view of silver-stained landmark 2-D protein spots,
depicted in their original position in the representative gels of
Fig. 1. Lanes 1 to 3 show gels of unstimulated (0d), 14-day stimu-
lated (14d) and 60-day stimulated (60d) fastmuscles, respectively.
The gradual change in the expression levels of fast Troponin-I (A;
TnI), slow Troponin-T (B; TnT) and the various fast and slowmyo-
sin light chains (C; MLCs) clearly demonstrated that the chronic
low-frequency stimulation of the peroneal nerve induced a fast-to-
slow fibre transition process in the tibialis anteriormuscle.
3.3 Identification of protein species with a changed
expression pattern in stimulated fast muscle
Taking these above described isoform switching of troponin
and myosin light chain as standards for the dynamic pro-
cess of fibre transformation, we then determined the overall
changes in the accessible fast muscle proteome after 2 and
8.5 wk of conditioning. Figure 3 illustrates the master 2-D
reference gel of chronic low-frequency stimulated fast mus-
cle. Shown is a silver-stained gel of 60-day stimulated fast
muscle. Muscle proteins with a drastically different expres-
sion level, as determined by fluorescent DIGE analysis
(Figs. 1D and F), are marked by circles and are listed in
Table 1. Following chronic electrostimulation, a differential
expression pattern was observed for 41 protein species with
29 increased and 12 decreased muscle proteins. Identified
classes of proteins that change during the fast-to-slow tran-
sition process belong to the contractile machinery, ion
homeostasis, vascularization, metabolism and stress.
Increased protein species include the oxygen transporters
hemoglobin and myoglobin, slow-twitch isoforms of con-
tractile elements such as myosin light chain, MHC, actin,
troponin I and troponin T, the fatty acid transporters albu-
min and FABP-3, mitochondrial proteins including Cyto-
chrome-c oxidase, NADH-ubiquinone oxidoreductase, F1
complex ATP synthase, proteolysis-inducing factor, pyruvate
dehydrogenase, ES1 protein homologue and electron-trans-
ferring flavoprotein, stress proteins such as HSP-27, a-crys-
tallin-related HSP-B6, aB-crystalline and HSP-10, the
anion-channel VDAC-1, the enzymes pyruvate kinase and
superoxide dismutase, as well as ankyrin, cofilin-2 and
transgelin. The fold-change in transgelin expression could
not be determined due to an obstructing troponin-contain-
ing spot in 0- and 14-day stimulated samples (not shown).
However, a distinct 2-D spot representing transgelin was
identified in 60-day stimulated specimens. See below for the
immunoblot analysis of transgelin in transforming fibres.
In contrast to the large number of increased muscle protein
species following chronic electrostimulation, a reduced
expression was shown for fast isoforms of the MHC and
myosin light chain, the enzyme aldose reductase and the
cytosolic malate dehydrogenase, the cytosolic Ca21-binding
protein parvalbumin, histone-4, the binding protein of the
glycerophospholipid phosphotidylethanolamine, and key
glycolytic enzymes such as aldolase, triosephosphate isom-
erase, phosphoglycerate kinase and glycerol-3-phosphate
dehydrogenase.
Proteins of interest, that had been identified by DIGE
analysis to exhibit a significant change in their expression
following chronic low-frequency stimulation, were picked
from preparative silver-stained 2-D gels and subsequently
identified by ESI-MS/MS. Figure 4 shows a representative
overview of transformation biomarkers with expanded views
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Figure 3. Master 2-D reference
gel of chronic low-frequency
stimulated fastmuscle. Shown is
a silver-stained 2-D gel of 60-day
stimulated fast muscle. IEF has
been carried out on 24 cm pH 3–
10 IPG strips in the first dimen-
sion and standard 12% poly-
arcylamide slab gels in the sec-
onddimension. ThepH-values of
the first dimension gel system
and molecular mass standards
(in kDa) of the second dimension
are indicated on the top and on
the left of the panels, respec-
tively. Muscle proteins with a
drastically different expression
level, as determined by fluores-
cent DIGE analysis (Fig. 1), are
marked by circles and are num-
bered 1–41. See Table 1 for a
detailed listingof skeletalmuscle
proteins with a changed abun-
dance in chronic low-frequency
stimulated fastmuscle.
of the 2-D spot pattern of specific muscle proteins. Changes
in individual 2-D spots demonstrated the differential effect
of chronic electrostimulation on the various classes of
muscle proteins. The observed drastic increase of the slow
MHC isoform at 14 and 60 days of stimulation (Fig. 4A) was
in stark contrast to the transient increase in the cytosolic
Ca21-binding protein parvalbumin and the oxygen-carrier
myoglobin after 2 wk of stimulation followed by a decrease
at day 60 of muscle conditioning (Figs. 4B and C). A con-
tinuous increase in the abundance of haemoglobin, the
cardiac fatty acid binding protein FABP-3, Cytochrome c,
the heat shock proteins aB-crystallin and HSP-b6, and the
actin binding protein cofilin-2 were revealed by DIGE anal-
ysis (Figs. 4D–I). Since the relatively low-abundance protein
cofilin-2 had not previously been implicated to play a role in
muscle transformation, this protein may represent poten-
tially a new biomarker of the fast-to-slow transition process.
This finding clearly demonstrates the superior sensitivity of
DIGE analysis as compared to conventional proteomic
approaches employing silver or commassie staining. Repre-
sentative 2-D spots of transgelin, another newly identified
potential biomarker of fibre shifting, are not shown due to
the fact that this protein spot was covered in electro-
phoretically separated 0- and 14-day stimulated samples by
a 2-D spot representing fast troponin. It was therefore not
possible to determine the exact degree of transgelin increase
following chronic low-frequency stimulation, but the pro-
tein was clearly identified in 60-day stimulated fibres. In
order to determine the fate of transgelin during the fast-to-
slow transition process, immunoblotting was employed as
described below.
3.4 Immunoblot analysis of fast-to-slow transition
process following chronic electrostimulation
To confirm the results from our DIGE analysis, changes in
the abundance of potential new biomarkers of muscle trans-
formation were investigated by immunoblot analysis. A
select group of proteins, which were reliably recognized by
antibody labelling, were studied in 0-, 14-, and 60-day chronic
electrostimulated specimens. To demonstrate a successful
fast-to-slow transition, and in order to provide internal stand-
ards of established alterations in known muscle proteins [4],
the immunodecoration of the fast and slow isoforms of the
sarcoplasmic reticulum Ca21-ATPase and the MHCwere car-
ried out. As illustrated in Figs. 5A–D, a drastic increase in the
slow isoforms SERCA2 and MHCs were observed and a con-
comitant decreased abundance of their fast counterparts,
SERCA1 and MHCf. Although antibodies to fast MHCdo not
differentiate between the various isoforms of this contractile
protein, the gradual replacement of MHCs from the MHCII
isoforms to MHCI has previously been demonstrated by
detailed gel electrophoretic analyses as reviewed by Pette et al.
[4, 48]. Thus, the immunoblotting survey shown here con-
firmed the previously described alterations in Ca21-uptake
units of the sarcoplasmic reticulum during muscle con-
ditioning and the modified myosin isoform expression pat-
tern in fibres with slower switch characteristics, and thereby
the usefulness of employing 1-D immunoblotting to deter-
mine changes in the expression of muscle marker proteins.
The visualization of antibody binding by ECL revealed a
drastic increase in DIGE-determined biomarkers of fibre type
shifting, such as the muscle-specific cofilin-2 protein,
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Figure 4. Differential expression pattern of skeletal muscle pro-
teins following chronic low-frequency stimulation. Shown is an
expandedviewof silver-stained2-Dprotein spots, depicted in their
original position in the representative gels of Fig. 1, which show a
significant change in abundance as judged by DIGE analysis.
Lanes 1 to 3 show gels of unstimulated (0d), 14-day stimulated
(14d) and 60-day stimulated (60d) fast muscles, respectively.
Panels A to I illustrate the gradual change in the expression levels
of muscle markers MHC, parvalbumin, myoglobin, hemoglobin,
cardiac fatty acid binding protein (FABP-3), Cytochrome c, aB-
crystallin, heat shock protein HSP-B6 and cofilin-2.
the heat shock protein aB-crystallin, transgelin and the car-
diac fatty acid binding-protein FABP-3 (Figs. 5E–H). The
immunoblot analysis clearly agreed with the results from the
DIGE screening of the muscle transition process. It con-
firmed the dramatic increase in the expression of new
markers of the fast-to-slow transformation process, such as
cofilin-2 and transgelin, which had not previously been
described by conventional biochemical studies.
4 Discussion
Fibre type shifting plays an important role during develop-
ment, mature muscle adaptation processes, ageing and
many neuromuscular diseases [1–4]. It is therefore essential
to identify reliable skeletal muscle protein markers of fast-to-
slow muscle transformation, which might be helpful in
establishing new molecular indicators of physiological and
pathological fibre alterations. Building on previously estab-
lished 2D skeletal muscle reference maps [10, 11], we carried
out a comprehensive proteomic profiling of the chronic low-
frequency stimulated rabbit tibialis anterior muscle and
determined changes in the expression pattern of key muscle
protein species. DIGE analysis and ESI-MS/MS for protein
Figure 5. Immunoblot analysis of key skeletal muscle proteins
following chronic low-frequency stimulation. Shown are iden-
tical immunoblots labelled with antibodies to the slow SERCA2
isoform of the sarcoplasmic reticulum Ca21-ATPase (A), the fast
SERCA1 isoform of the sarcoplasmic reticulum Ca21-ATPase (B),
the slow MHCs isoform of the MHC (C), the fast MHCf isoform of
the MHC (D), cofilin-2 (E), aB-crystallin (F), transgelin (G), and the
cardiac fatty acid binding protein FABP-3 (H). Lanes 1 to 3 repre-
sent muscle preparations from 0-, 14- and 60-day low-frequency
stimulated tibialis anterior muscle, respectively.
identification and immunoblotting clearly confirmed estab-
lished changes in representative protein species from dis-
tinct functional muscle protein groupings, and uncovered
interesting new transformation biomarkers. This included a
drastic stimulation-induced increase in the abundance of the
actin binding protein cofilin-2 and the cytoskeletal protein
transgelin. Thus, besides confirming the findings from
numerous physiological and biochemical studies on muscle
conditioning over the past decades [2, 4, 41] and extending
the preliminary results from a nonfluorescent proteomics
study [35], this report clearly shows the usefulness of
employing high-resolution 2-DE and ESI-MS/MS for identi-
fying new skeletal muscle biomarkers.
Changes in nutritional supply, fluctuations in hormonal
factors, alterations in neuromuscular activity and modifica-
tions in mechanical loading conditions may all affect skeletal
muscle plasticity [4]. Consequently, resistance training,
endurance training, muscle immobilization and zero-gravity
conditions may trigger distinct adjustments in the skeletal
muscle proteome [1, 3, 59]. In addition, fibre type shifting or
major alterations in muscle isoform expression levels also
occur in various pathophysiological situations, such as trau-
matic denervation, disuse atrophy and sarcopenia of old age
[60–62]. The DIGE analysis presented here supports the idea
that the fast-to-slow transition process includes distinct
changes in the muscle protein complement that is involved
in the contractile machinery, ion homeostasis, excitation-
contraction coupling, capillarization, metabolism, stress re-
sponse and cytoskeletal support. The observed alterations in
the expression of cofilin-2, transgelin, hemoglobin, cardiac
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fatty acid binding protein FABP-3, albumin, aB-crystallin,
HSP-27 and myoglobin are especially interesting findings
for a better understanding of the transformation process. A
chronic increase in contractile activity and a shift to oxidative
muscle metabolism would require a higher demand in oxy-
gen and fuel supply in the form of fatty acids. Consequently
the drastic increase in the oxygen-transporter myoglobin, the
intracellular fatty acid binding protein FABP-3 and the
extracellular fatty acid transporter albumin strongly indicates
that these three central metabolic regulators could function
as limiting factors of oxidative metabolism in fast fibres [40,
63]. The findings from our DIGE analysis clearly establish
the small cytosolic FABP-3 protein as a suitable biomarker of
muscle fibre type shifting. It is, however, difficult to make
proper conclusions about the changed levels in the blood
protein hemoglobin, which increased concentration might
be due to varying amounts of this oxygen carrier being
trapped in muscle tissue.
In agreement with the stimulation-induced change in
the contractile apparatus towards slower isoforms, the de-
crease in glycolytic proteins and the increase in mitochon-
drial enzymes, an increase in markers of capillarization
could be expected [64]. This report shows for the first time
that the cytoskeletal protein transgelin [65] exists in long-
term stimulated skeletal muscles. Transgelin, also referred to
as SM22a [66], has been localized to vascular smooth muscle
cells throughout the arterial and venous system. It has been
described in visceral smooth muscle cells in various organs
and the heart, but as being absent from mature skeletal
muscle [66]. The electrostimulation-dependent induction
revealed by DIGE analysis suggests transgelin as another
excellent biomarker of fast-to-slow fibre transition. The same
is true for the actin binding protein cofilin-2, which plays a
critical role in actin filament dynamics [67]. The muscle-spe-
cific cofilin isoform is believed to be important for the growth
of myofibrils in developing and regenerating muscle cells
[68, 69]. In analogy, cofilin-2 up-regulation in transforming
fibres could also be a response to remodeling of the con-
tractile apparatus towards slower twitch properties.
Interestingly, during muscle transformation, identifiable
heat shock proteins were found to be exclusively increased in
their abundance, indicating that fibre modifications probably
depend heavily on chaperone function. As previously dis-
cussed by Neufer and Benjamin [70], aB-crystallin expres-
sion may be directly regulated by the demand for oxidative
metabolism. Besides aB-crystallin, also its ancestral-related
heat shock protein HSP-27 and chaperonin-10 were
increased following chronic low-frequency stimulation. Pre-
vious studies by Maier et al. [71] have shown that degenera-
tion–regeneration cycle occur during stimulation-induced
changes. Besides transdifferentiation from fast to slow
fibres, other processes seem to occur in parallel such as the
degradation of the fastest glycolytic fibre population and the
activation of the satellite cell pool for the creation of new
fibres with slower twitch characteristics. In contrast to the
fast-to-slow transformation mechanism, in severe muscle
degeneration, as occurs in X-linked muscular dystrophy,
there appears to be a differential expression pattern of key
chaperones. A recent MS-based proteomics and immuno-
blotting survey revealed that HSP-20, GRP-75 and HSP-90
are reduced in dystrophin-deficient fibres. On the other
hand, cvHSP and HSP110 were drastically increased in their
expression in dystrophinopathy [26]. This suggests aB-crys-
tallin as another suitable biomarker of fibre type shifting.
In conclusion, the proteomic profiling of the fast-to-slow
fibre transition process reported here has clearly shown that
skeletal muscles represent a tissue type with an extremely
high degree of plasticity that can swiftly adapt to changed
functional demands on the protein expression level. The
previous generation of a detailed 2-D protein map of the sol-
uble gastrocnemius proteome versus its soleus counterpart by
Gelfi et al. [17] has established a high density of MLC-1f, fast
troponin I, glycolytic enzymes, creatine kinase and adenylate
kinase in gastrocnemius muscle and MLC1s, slow troponin
C, myoglobin and carbonic anhydrase 3 as slow-twitch
markers present at high concentration in soleus fibres. In
analogy, the DIGE analysis presented here demonstrated
that the transformed tibialis anterior muscle exhibited high
levels of MLC1s, MHCs, slow troponin I, myoglobin and low
levels of MLC1f, fast troponin I and glycolytic enzymes.
Hence, the conditioned fast muscle protein complement
resembles that of a slow-twitching soleus muscle. This study
has clearly established a more comprehensive picture of the
overall fiber transition process than has been previously
reported [4]. Modern proteomics technology presents itself as
an ideal biochemical tool for the study of complex biological
systems and processes, such as the finely tuned physiological
adaptation of skeletal muscles following chronic low-fre-
quency stimulation.
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